Cite

HARVARD Citation

    Zhuang, Y. et al. (2020). Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes. Medicine. 99 (30), p. . [Online]. 
  
Back to record